Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...

These results are significant for mRNA vaccine research and ... Today, many other lipid nanoparticle-oligonucleotide formulations have been developed and are under clinical evaluation for the ...

Shares of Prime Medicine (NASDAQ: PRME) are surging on Thursday. The move up comes as the S&P 500 and Nasdaq Composite gained ...

The global lipid nanoparticles market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a CAGR of 5.2%, while the LNP services market is projec ...

Scientists unlock the potential of fenugreek-based lipid nanoparticles to improve diabetes ... validation through in vivo studies and clinical trials is required. The research mapped interactions ...

Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics ... technology platforms, research and clinical development plans, and preclinical data and other statements ...

PLYMOUTH MEETING, PA, USA I March 13, 2025 I INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help ...

Getting mRNA into the brain could allow scientists to instruct brain cells to produce therapeutic proteins that can help ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...

News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ: ...